Zollinger-Ellison syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
| Line 17: | Line 17: | ||
*In 1960s, gastrin was described as a main pathogenesis of gastric hyperacidity by Dr. Lester.<ref name="pmid17053435">{{cite journal| author=Hou W, Schubert ML| title=Gastric secretion. | journal=Curr Opin Gastroenterol | year= 2006 | volume= 22 | issue= 6 | pages= 593-8 | pmid=17053435 | doi=10.1097/01.mog.0000245538.43142.87 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17053435 }} </ref> | *In 1960s, gastrin was described as a main pathogenesis of gastric hyperacidity by Dr. Lester.<ref name="pmid17053435">{{cite journal| author=Hou W, Schubert ML| title=Gastric secretion. | journal=Curr Opin Gastroenterol | year= 2006 | volume= 22 | issue= 6 | pages= 593-8 | pmid=17053435 | doi=10.1097/01.mog.0000245538.43142.87 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17053435 }} </ref> | ||
* Roderic Gregory and Hilda Tracy of Liverpool proved that gastrin is the cause of Zollinger-Ellison syndrome. <ref name="pmid3851712">{{cite journal| author=Leske JS| title=Hyperglycemic hyperosmolar nonketotic coma: a nursing care plan. | journal=Crit Care Nurse | year= 1985 | volume= 5 | issue= 5 | pages= 49-56 | pmid=3851712 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3851712 }}</ref> | * Roderic Gregory and Hilda Tracy of Liverpool proved that gastrin is the cause of Zollinger-Ellison syndrome. <ref name="pmid3851712">{{cite journal| author=Leske JS| title=Hyperglycemic hyperosmolar nonketotic coma: a nursing care plan. | journal=Crit Care Nurse | year= 1985 | volume= 5 | issue= 5 | pages= 49-56 | pmid=3851712 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3851712 }}</ref> | ||
* Radioimmunoassay was developed for assessment of gastrin level in 1967 and 1968.<ref name="StrempleAbramoff1967">{{cite journal|last1=Stremple|first1=JohnF.|last2=Abramoff|first2=Peter|last3=Van Oss|first3=CarelJ.|last4=Wilson|first4=StuartD.|last5=Ellison|first5=EdwinH.|title=ANTIBODIES TO SYNTHETIC HUMAN GASTRIN I|journal=The Lancet|volume=290|issue=7527|year=1967|pages=1180–1182|issn=01406736|doi=10.1016/S0140-6736(67)91895-8}}</ref> | * Radioimmunoassay was developed for assessment of gastrin level in 1967 and 1968.<ref name="StrempleAbramoff1967">{{cite journal|last1=Stremple|first1=JohnF.|last2=Abramoff|first2=Peter|last3=Van Oss|first3=CarelJ.|last4=Wilson|first4=StuartD.|last5=Ellison|first5=EdwinH.|title=ANTIBODIES TO SYNTHETIC HUMAN GASTRIN I|journal=The Lancet|volume=290|issue=7527|year=1967|pages=1180–1182|issn=01406736|doi=10.1016/S0140-6736(67)91895-8}}</ref><ref name="McGuiganTrudeau1968">{{cite journal|last1=McGuigan|first1=James E.|last2=Trudeau|first2=Walter L.|title=Immunochemical Measurement of Elevated Levels of Gastrin in the Serum of Patients with Pancreatic Tumors of the Zollinger-Ellison Variety|journal=New England Journal of Medicine|volume=278|issue=24|year=1968|pages=1308–1313|issn=0028-4793|doi=10.1056/NEJM196806132782402}}</ref> | ||
==References== | ==References== | ||
Revision as of 16:16, 15 March 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
|
Zollinger-Ellison syndrome Microchapters |
|
Differentiating Zollinger-Ellison syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Zollinger-Ellison syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Zollinger-Ellison syndrome historical perspective |
|
Zollinger-Ellison syndrome historical perspective in the news |
|
Risk calculators and risk factors for Zollinger-Ellison syndrome historical perspective |
Overview
In 1955, Zollinger and Ellison published their seminal paper on gastrinomas wherein the Zollinger-Ellison syndrome was first discussed.
Historical Perspective
- In 1955, Zollinger and Ellison announced their concept about ulcerogenic islet cell tumor which caused marked ulcer diathesis due to gastric hyperacidity.[1]
- Dr. Robert M. Zollinger and Dr. Edwin H. Ellison announced their theory at annual meeting of the American Surgical Association in Philadelphia in April 1956.[2]
- This concept raised from clinical case of two women who presented with perforated jejunal ulcers accompanied with severe ulcer diathesis.
- One of the patients was a 36 year-old woman with past history of 8 years abdominal pain and diarrhea. A laparotomy revealed perforated jejunal ulcers with severe recurrent hemorrhage. Although she underwent two subtotal gastric resections, transabdominal vagotomy, and transthoracic vagotomy, her symptoms were constantly persistant. Finally she underwent total gastrectomy; however, she died due to anastomic leakage from the surgery. Her autopsy was in favor of non-beta pancreatic islet cell tumors.[3]
- The other patient was a 19 year-old women with 2 years of upper abdominal pain. She underwent a surgery in July 1953 and diagnosed with two perforated jejunal ulcers. A truncal vagotomy and a radical subtotal gastrectomy were performed in January 1954. This operation was called as a dream operation for ulcers by Zollinger. Due to unsuccessful results of the operation, she experienced radiation therapy to her stomach. Eventually, total gastrectomy was performed. The results described a non-beta islet cell carcinoma with lymph node metastasis. Hopefully she survived and gave birth to two children.
- In 1956, Ben Eiseman of Denver, Colorado, presented the same experience with one of his patients and called the condition as a Zollinger-Ellison syndrome.[4]
- Discovery of insulinoma in 1927 and malignant carcinoid syndrome in 1953, have exceeded the presentation and discovery of Zollinger-Ellison syndrome.[5][6]
- In 1960s, gastrin was described as a main pathogenesis of gastric hyperacidity by Dr. Lester.[7]
- Roderic Gregory and Hilda Tracy of Liverpool proved that gastrin is the cause of Zollinger-Ellison syndrome. [8]
- Radioimmunoassay was developed for assessment of gastrin level in 1967 and 1968.[9][10]
References
- ↑ Zollinger RM (1991). "[The history of the Zollinger-Ellison syndrome]". Ann Gastroenterol Hepatol (Paris). 27 (5): 223–6. PMID 1746876.
- ↑ ZOLLINGER RM, ELLISON EH (1955). "Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas". Ann Surg. 142 (4): 709–23, discussion, 724–8. PMC 1465210. PMID 13259432.
- ↑ Kaplan, Edwin L.; Tanaka, Reiko; Ito, Koichi; Younes, Nidal; Friesen, Stanley R. (1994). "The discovery of the Zollinger-Ellison syndrome". Journal of Hepato-Biliary-Pancreatic Surgery. 1 (5): 509–516. doi:10.1007/BF01211912. ISSN 0944-1166.
- ↑ Chey WY, Chang TM, Lee KY, Sun G, Kim CK, You CH; et al. (1989). "Ulcerogenic tumor syndrome of the pancreas associated with a nongastrin acid secretagogue". Ann Surg. 210 (2): 139–49. PMC 1357819. PMID 2757418.
- ↑ Wilder, Russell M.; Allan, Frank N.; Power, M. H.; Robertson, H. E. (1927). "CARCINOMA OF THE ISLANDS OF THE PANCREAS". Journal of the American Medical Association. 89 (5): 348. doi:10.1001/jama.1927.02690050014007. ISSN 0002-9955.
- ↑ Epelboym I, Mazeh H (2014). "Zollinger-Ellison syndrome: classical considerations and current controversies". Oncologist. 19 (1): 44–50. doi:10.1634/theoncologist.2013-0369. PMC 3903066. PMID 24319020.
- ↑ Hou W, Schubert ML (2006). "Gastric secretion". Curr Opin Gastroenterol. 22 (6): 593–8. doi:10.1097/01.mog.0000245538.43142.87. PMID 17053435.
- ↑ Leske JS (1985). "Hyperglycemic hyperosmolar nonketotic coma: a nursing care plan". Crit Care Nurse. 5 (5): 49–56. PMID 3851712.
- ↑ Stremple, JohnF.; Abramoff, Peter; Van Oss, CarelJ.; Wilson, StuartD.; Ellison, EdwinH. (1967). "ANTIBODIES TO SYNTHETIC HUMAN GASTRIN I". The Lancet. 290 (7527): 1180–1182. doi:10.1016/S0140-6736(67)91895-8. ISSN 0140-6736.
- ↑ McGuigan, James E.; Trudeau, Walter L. (1968). "Immunochemical Measurement of Elevated Levels of Gastrin in the Serum of Patients with Pancreatic Tumors of the Zollinger-Ellison Variety". New England Journal of Medicine. 278 (24): 1308–1313. doi:10.1056/NEJM196806132782402. ISSN 0028-4793.